Loading...
Market
Will the MVA-BN vaccine be procured by at least five UN agencies by the end of 2024?
2
Resolution / Starting Odds
Yes • 50%
No • 50%
Official announcements from UN agencies and WHO reports
Story
WHO Prequalifies Bavarian Nordic's MVA-BN as First Mpox Vaccine for Emergency Use
Sep 13, 2024, 10:24 AM
The World Health Organization (WHO) has prequalified Bavarian Nordic's MVA-BN vaccine as the first vaccine against mpox. This approval marks a significant step towards expanding access and reducing transmission in high-risk communities, particularly in Africa where the disease has been prevalent. The MVA-BN vaccine, which is also indicated for smallpox, is now eligible for procurement by UN agencies, facilitating broader distribution to those in need. WHO Director-General Dr. Tedros Adhanom Ghebreyesus emphasized the importance of this development in the fight against mpox. The vaccine has been approved for emergency use in adults.
View original story
Similar markets
Yes • 50%
No • 50%
Yes • 50%
No • 50%
1-5 • 25%
6-10 • 25%
11-15 • 25%
More than 15 • 25%
Yes • 50%
No • 50%
UK Government • 25%
Gavi • 25%
WHO • 25%
Other • 25%
Yes • 50%
No • 50%
Africa CDC • 25%
Gavi • 25%
WHO • 25%
Other • 25%
